Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.Marcus A Carden,Manila Gaddh,Abhinav Hoskote, Michael Brown, Virginia Merrill,Sean R Stowell,Shanmuganathan Chandrakasan,Ana Antun,Ragini Kudchadkar, Sarah Kotanchiyev,David L Jaye,Imre BodóBlood advances(2020)引用 5|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要